We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LEVOTHYROXINE SANDOZ (Sandoz Pty Ltd)
Product name
LEVOTHYROXINE SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
117 (255 working days)
Active ingredients
levothyroxine sodium
Registration type
New generic medicine
Indication
Levothyroxine Sandoz is indicated for the management of demonstrated thyroid hormone deficiency.
Levothyroxine Sandoz is also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.